To overcome this problem and given that IL6 is the gold-standard activator of STAT3 via pY70539 and ccRCC patients exhibit sustained high IL6 plasma levels30 we treated the cells with IL6 for Y705 phosphorylation. The gene discussed is STAT3; the disease is nonpapillary renal cell carcinoma.